Yulithira
NDC 82249-610, Everolimus, tablet, from CivicaScript, LLC.
- Product NDC
- 82249-610
- Status
- Listed
- Labeler
- CivicaScript, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205426
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82249-610 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS2.5 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82249-610-30 | 82249061030 | 30 TABLET in 1 BOTTLE (82249-610-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5e325efa-8ae6-4dac-b59b-d7c74c73186c
Use it
Look up 82249-610 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82249-610 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82249-610. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.